Low-dose paclitaxel–coated versus uncoated percutaneous transluminal balloon angioplasty for femoropopliteal peripheral artery disease. Circulation. 2017; 135: 2227-2236.

Published: 28th November 2017

Authors: Schroeder H, Werner M, Meyer D-R, Reimer P, Krüger K, Jaff MR et al.

Conclusion

Some 222 patients were randomized 3:1 to drug-coated or plain angioplasty. Patency at twelve months was better with the drug-coated balloon (83.9 per cent) compared to the plain balloon (60.6 per cent, P<0.001). Similarly, freedom from target lesion revascularization at twelve months was improved: 5.9 versus 16.7 per cent, P=0.014.

Pubmed Link

Your comments

0 Comments